{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:30:01Z","timestamp":1770816601758,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["843001801"],"award-info":[{"award-number":["843001801"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.lanepe.2024.100987","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T04:56:33Z","timestamp":1719982593000},"page":"100987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Contrast-enhanced mammography versus conventional imaging in women recalled from breast cancer screening (RACER trial): a multicentre, open-label, randomised controlled clinical trial"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2598-6219","authenticated-orcid":false,"given":"Lidewij M.F.H.","family":"Neeter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"Nelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.P.J.","family":"Raat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Frotscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katya M.","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte A.B.","family":"Essers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein L.","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim E.","family":"Wildberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-6956","authenticated-orcid":false,"given":"Marc B.I.","family":"Lobbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2024.100987_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.breast.2014.03.002","article-title":"Breast cancer screening halves the risk of breast cancer death: a case-referent study","volume":"23","author":"Paap","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.lanepe.2024.100987_bib2","series-title":"Uitvoeringskader bevolkingsonderzoek borstkanker","first-page":"1","author":"Rijksinstituut voor Volksgezondheid en Milieu (RIVM)","year":"2023"},{"key":"10.1016\/j.lanepe.2024.100987_bib3","series-title":"Bevolkingsonderzoek borstkanker - factsheet","author":"Rijksinstituut voor Volksgezondheid en Milieu (RIVM)","year":"2021"},{"key":"10.1016\/j.lanepe.2024.100987_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/MLR.0b013e3181e57918","article-title":"Cost of breast-related care in the year following false positive screening mammograms","volume":"48","author":"Chubak","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.lanepe.2024.100987_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/eb-2012-100608","article-title":"Psychological consequences of false-positive screening mammograms in the UK","volume":"18","author":"Bond","year":"2013","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.lanepe.2024.100987_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-014-2959-x","article-title":"Re-attendance at biennial screening mammography following a repeated false positive recall","volume":"145","author":"Klompenhouwer","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.lanepe.2024.100987_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13244-019-0756-0","article-title":"Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review","volume":"10","author":"Zanardo","year":"2019","journal-title":"Insights Imaging"},{"key":"10.1016\/j.lanepe.2024.100987_bib8","first-page":"1423","article-title":"A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer. Thorac","volume":"11","author":"Xiang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.lanepe.2024.100987_bib9","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1016\/j.clbc.2018.06.003","article-title":"Diagnostic value of contrast-enhanced spectral mammography for screening breast cancer: systematic review and meta-analysis","volume":"18","author":"Zhu","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.lanepe.2024.100987_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.breast.2020.06.005","article-title":"Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: a systematic review and meta-analysis","volume":"53","author":"Suter","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.lanepe.2024.100987_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.breast.2016.04.008","article-title":"Diagnostic performance of contrast-enhanced spectral mammography: systematic review and meta-analysis","volume":"28","author":"Tagliafico","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.lanepe.2024.100987_bib12","first-page":"1668","article-title":"Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme","volume":"24","author":"Lobbes","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.lanepe.2024.100987_bib13","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1007\/s00330-016-4336-0","article-title":"Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study","volume":"26","author":"Lalji","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.lanepe.2024.100987_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejrad.2017.07.004","article-title":"Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits","volume":"94","author":"Houben","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.lanepe.2024.100987_bib15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1186\/s13063-019-3867-5","article-title":"Rapid access to contrast-enhanced spectral mammography in women recalled from breast cancer screening: the RACER trial study design","volume":"20","author":"Neeter","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.lanepe.2024.100987_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1148\/radiol.2021201948","article-title":"Contrast-enhanced mammography: state of the art","volume":"299","author":"Jochelson","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.lanepe.2024.100987_bib17","series-title":"Contrast enhanced mammography (CEM): a supplement to ACR BI-RADS\u00ae Mammography","first-page":"1","author":"Lee","year":"2013"},{"key":"10.1016\/j.lanepe.2024.100987_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.lanepe.2024.100987_bib19","doi-asserted-by":"crossref","first-page":"W267","DOI":"10.2214\/AJR.17.19355","article-title":"Contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts","volume":"211","author":"Sorin","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.lanepe.2024.100987_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1148\/radiol.212530","article-title":"Contrast-enhanced mammography versus contrast- enhanced breast MRI: a systematic review and meta-analysis","volume":"305","author":"P\u00f6tsch","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.lanepe.2024.100987_bib21","article-title":"Contrast-enhanced mammography and breast MRI: friends or foes?","volume":"307","author":"Lobbes","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.lanepe.2024.100987_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/bjs.7371","article-title":"Effect of abnormal screening mammogram on quality of life","volume":"98","author":"Van der Steeg","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.lanepe.2024.100987_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.seminoncol.2019.03.002","article-title":"Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early stage disease","volume":"46","author":"Thomas","year":"2019","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lanepe.2024.100987_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/RLI.0000000000000068","article-title":"Radiation exposure of contrast-enhanced spectral mammography compared with full-field digital mammography","volume":"49","author":"Jeukens","year":"2014","journal-title":"Invest Radiol"},{"key":"10.1016\/j.lanepe.2024.100987_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1148\/radiol.10100655","article-title":"Risk of radiation-induced breast cancer from mammographic screening","volume":"258","author":"Yaffe","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.lanepe.2024.100987_bib26","series-title":"Position statement on radiation risks from medical imaging procedures","first-page":"330","author":"American Association of Physicists in Medicine","year":"2018"},{"key":"10.1016\/j.lanepe.2024.100987_bib27","doi-asserted-by":"crossref","first-page":"908.e11","DOI":"10.1016\/j.crad.2018.05.031","article-title":"Utility of routine use of breast ultrasound following contrast-enhanced spectral mammography","volume":"73","author":"Klang","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.lanepe.2024.100987_bib28","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1007\/s00330-014-3271-1","article-title":"Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis","volume":"24","author":"Cheung","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.lanepe.2024.100987_bib29","series-title":"European guidelines for quality assurance in breast cancer screening and diagnosis","first-page":"1","author":"Perry","year":"2006"},{"key":"10.1016\/j.lanepe.2024.100987_bib30","series-title":"AtlasBI-RADS BBreast imaging reporting and data system","author":"D\u2019Orsi","year":"2013"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224001546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224001546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:10:50Z","timestamp":1762639850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776224001546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"alternative-id":["S2666776224001546"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100987","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contrast-enhanced mammography versus conventional imaging in women recalled from breast cancer screening (RACER trial): a multicentre, open-label, randomised controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101068","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100987"}}